Cardinal Health, Inc.· CAH

🇺🇸 US · LargeSP500NYSE

Healthcare Medical - Distribution Website

Price: $240.49
Day: -2.71%
Mkt Cap: $56.32B
52W Range: $145.87 – $258.30
Volume: 1.58M
Beta: 0.52

5D Framework

Company Overview

Snapshot of fundamentals, performance, and 5D scores.

5D scores: Quality 2.3, Peers 3.2, Valuation 5.0, Analysts 3.6, Holdings 3.1 (out of 5)
Market: $240.49 a share, market cap $56.32B, +60.0% over 12 months
Company: Healthcare · Medical - Distribution, 61,344 employees, NYSE

Blog

Company Profile

Business fundamentals and company information

Business Description

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

Key Details

CEO

Jason Hollar

Employees

61,344

Headquarters

Dublin, OH, US

IPO Date

Aug 1983

Exchange

New York Stock Exchange

Phone

614 757 5000

Healthcare · Medical - Distribution

SEC filings

10-KAug 11, 2026 10-QApr 30, 2026 8-KAug 11, 2026

Price Performance

Recent price action and historical returns

Price Performance

$240.49

Historical Returns

Price performance over time

1 Day

-2.71%

5 Day

+2.50%

1 Month

+1.73%

3 Months

+13.08%

6 Months

+10.80%

YTD

+17.03%

1 Year

+60.03%

3 Years

+170.88%

5 Years

+349.60%

10 Years

+200.69%

Revenue Analysis

How the business makes money, by product and geography

2026 revenue · 3 products

Revenue to Profit Flow · 2026

How revenue flows through the P&L: Products → Total Revenue → COGS → Gross Profit → operating costs (R&D, SG&A) → Operating Income → Tax / Interest → Net Income.

Learn how to read flow diagrams

5D Framework

Five lenses on the stock. Click any card to dive deeper.

Quality

Business fundamentals

2.3/5

Weak

View Details

Peers

Competitive position

3.2/5

Adequate

View Details

Valuation

Model-based valuation (vs. price)

5.0/5

Well below estimate

View Details

Analysts

Wall Street sentiment

3.6/5

Bullish

View Details

Holdings

Smart money flows

3.1/5

Neutral

View Details

How to read these dimensions

The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.